MedPath
NMPA Approval

盐酸西替利嗪

国药准字H20000299

February 1, 2024

Drug Information

盐酸西替利嗪

原料药

化学药品

February 1, 2024

Company Information

Applicant Company

Manufacturing Company

浙江省德清县新市镇果山头66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸西替利嗪 - NMPA 批准文号 | MedPath